-
The MENDS2 trial found that dexmedetomidine, when used for light sedation, had outcomes similar to those for propofol.
-
A shorter program could be more useful for smaller universities that may not have the resources available to implement a longer program.
-
These two trials had disparate findings with respect to interleukin-6 inhibition, with REMAP-CAP showing a benefit and COVACTA showing none.
-
In this retrospective analysis of COVID-19 patients hospitalized with cytokine storm, the use of corticosteroids combined with tocilizumab was associated with superior survival when compared to no immunomodulatory treatment; a combination of corticosteroids and anakinra; or corticosteroids, tocilizumab, or anakinra alone. Patients who received corticosteroids, either alone or in combination with anakinra, also experienced lower hospital mortality compared to no treatment.
-
By including ordinary people, researchers could create consent forms, and a consenting process, that is primarily suited to meeting the needs of potential participants.
-
Keep in mind the person who has who to digest informed consent information. Avoiding complex terminology could lead to better understanding among the laypeople who participate in clinical trials.
-
Some ethicists are unaware of how code status options are named and defined at their institutions. Researchers found that at some hospitals, code status options in the electronic medical record did not even match what was in the hospital policy. Ethics should be one of the experts in this area.
-
Researchers hope leaders can use these data to decide what resources to devote to ethics consultation.
-
Numerous real-life examples of artificial intelligence in healthcare already pose difficult ethical questions: Informed consent, patient privacy, transparency, allocation, and safety are a few. The authors of a recent paper argued artificial intelligence-related ethics training should begin in medical school.
-
Despite ongoing efforts to address disparities in Alzheimer’s disease and dementia care, much work remains. The authors of a recent report identified some of the barriers diverse populations are facing in accessing and receiving dementia care.
